One-visit ICS testing dominates in prenatal syphilis screening News item 21 February 2013 Pages: 3 - 3
Primary angioplasty the new first-line heart attack treatment in UK Media release 21 February 2013 Pages: 3 - 3
Screening justified for relatives of factor V Leiden carriers Clinical study 21 February 2013 Pages: 4 - 4
Radiochemotherapy toxicity costly in HNC, NSCLC patients Clinical study 21 February 2013 Pages: 5 - 5
Phase III trial of bevacizumab for colon cancer to continue Media release 21 February 2013 Pages: 6 - 6
Bavituximab advancing in phase II advanced breast cancer trial Media release 21 February 2013 Pages: 7 - 7
Dexlansoprazole kills the burn in erosive oesophagitis . . . Clinical study 21 February 2013 Pages: 8 - 8
Mercaptamine phase IIa trial in steatohepatitis initiated Media release 21 February 2013 Pages: 8 - 8
VITAL-1 phase III trial of cancer vaccine-GVAX terminated Media release 21 February 2013 Pages: 9 - 9
Promising results for novel cystic fibrosis drug targeting the CFTR Media release 21 February 2013 Pages: 10 - 10
Sapropterin improves endothelial dysfunction in sickle cell disease Media release 21 February 2013 Pages: 10 - 10
Adalimumab works long term to heal fistulas in Crohn's disease Media release 21 February 2013 Pages: 11 - 11
BP control during cardiac surgery linked to short-term outcome Media release 21 February 2013 Pages: 11 - 11
Intravesical chondroitin sulfate shows promise in bladder pain Media release 21 February 2013 Pages: 11 - 11
Aspirin not a wonder drug: careful patient selection important News item 21 February 2013 Pages: 12 - 12
Ezetimibe reduces LDL cholesterol in HIV patients receiving ART Clinical study 21 February 2013 Pages: 13 - 13
Delayed-release mesalazine provides sustained efficacy in UC Clinical study 21 February 2013 Pages: 14 - 14
Antipsychotics: acute use linked to dysphagia in older inpatients Clinical study 21 February 2013 Pages: 16 - 16
Pooled analysis shows superior GI tolerability of celecoxib Clinical study 21 February 2013 Pages: 16 - 16
Renal dysfunction: a possible late effect of high-dose methotrexate Clinical study 21 February 2013 Pages: 16 - 16
Abbott receives complete response letter from US FDA for hydrocodone with paracetamol [acetaminophen]. Media release 21 February 2013 Pages: 17 - 17